- Home
- Standardized Extracts
- Cat's Claw Extract
Cat's Claw Extract (Uncaria tomentosa) – Quinovic Acid Glycosides 5–10%
Uncaria tomentosa
- Marker compound
- Quinovic acid glycosides
- Standardisation
- 5–10% (HPLC)
- Assay method
- HPLC
- Plant part
- Bark
- Origin
- Peru, Brazil
Cat's Claw Extract (Uncaria tomentosa) – Quinovic Acid Glycosides 5–10%
Cat's Claw extract is produced from the bark of Uncaria tomentosa (Rubiaceae family) and supplied as a standardized extract powder, standardized to Quinovic acid glycosides. Available grades: 5%, 10%. Typical sourcing: Peru, Brazil. For B2B formulation in nutraceuticals & supplements.
5%10%
Specifications
| Botanical name | Uncaria tomentosa |
| Common names | Cat's claw, Uña de gato |
| Plant family / part | Rubiaceae / Bark |
| Marker compound | Quinovic acid glycosides |
| Phytochemical class | Terpenoids › Triterpenoids & triterpene saponins |
| Available grades | 5%, 10% |
| Assay method | HPLC |
| Pharmacopoeia & standards | USP, WHO monograph |
| Form | Standardized Extract |
| Origin | Peru, Brazil |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Joint & Bone Health
- Immune Support
Industries
Nutraceuticals & Supplements
Traditional systems: Latin American & Amazonian
Documentation
Batch Certificate of Analysis, Technical Data Sheet and MSDS available on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form